Team:Tuebingen/Demonstrate
Results
Success isn't about the end result, it's about what you learn along the way.- Vera Wang
Molecular Biology
Protein Expression
Our project divided protein expression and purification into two phases. The first hurdle that had to be overcome was the validation of the ToxAssay. Three proteins were needed. These were the LCwt, LCmut and SNAP25.
SNAP25.
Synaptosomal-associated protein 25 (SNAP-25) is a t-SNARE protein. It is account for the specificity of membrane fusion in neuronal cells by forming the SNARE complex. It is almost exclusively formed in brain tissues and executes fusion by forming a tight complex that brings the synaptic vesicle and plasma membranes together.
The SNAP25 protein was provided with a Strep-Tag to obtain optimal results in purification. The other proteins (LCwt and LCmut) were each modified with a His-Tag. The reason for this is the Western-Blot Assay, which should show by means of Strep-Tag binding antibodies how the SNAP25 is degraded. However, this assay was rejected due to poorly binding antibodies.
Cell Culture
Chemistry
Goal of the chemical part of this years project was to alter the sodium channel blocker Eslicarbazepine so it would bind to the light chain of the detoxified Botox. The Synthesis was executeted after the following schematic plan.
The step-to-step execution of the synthesis can be found in our labbook. For the first step of our synthesis we achieved a satisfying yield after testing two diffrent reaction pathways. Massspectroscopy as well as NMR-Ananlysis showed that the exchange of the carboxy group with an thiol group has been sucessfull. The yield was determined to be approximatley 40%. The second step of the synthesis was executeted simultanousley with the synthesis of the azide-donor necessary for the last reaction. After some experiments to alter the reaction, we were able to successfully synthesize the azide-donor. The drying of the azide-donor was critical, as the donor decomposes in vacuo and under mild heat. As it’s a non-explosive and air-stable salt, maybe drying it in a desiccator could be a solution. Nonetheless, the Donor is instabel as long it’s not completely dry and must be handled with care. But by using the sulfate salt, the reaction became much more safe. The chloride salt should not be used, and the sulfate salt is an easy to make, shock-resistant alternative.
After executing the second reaction step the analytic results indicated that no reaction took place. Massspectroscopy data suggested that after the reaction both reactants were still present in their original Form as well as cleavage products of the 2,2'-Dithiodiethylamine. During troubleshooting we hypothesized that changing the conditions of the reaction would lead to a positive outcome. We considered Possible changes the reactiontime and -tempreature. The reactiontime might have been to short the activation energy of transitional state was to high. A possibel solution for the first problem would be to increase the reaction time. For the secon problem it would be to increase the reaction temperature. But with the already unstable 2,2'-Dithiodiethylamine, this might just destroy the reactants. A catalysator would be another option to decrease the activation energy. We also considered to take a whole diffrent approach. Because of the alkene as by-product, the yield was always very small. If the alkene was chosen as the product, targeting it with an S-Nucleophile, the yield could be improved. Plus, the disulfide binding could be produced simply by using a molecule with a disulfid binding. Due to a shortage of time, we were unable to test our possible solutions.
We tried to reobtain the reactants, but the Thio-Eslicarbazepine is not stable in water. The thiol group tends to decay, forming the alkene. As the solvent for the second reaction step was a water- THF-mixture, the Thio-Eslicarbazepine couldn't be reextracted in a sufficient amount. As a result we weren't able to test the Thio-Eslicarbazepine on our neuron-like cells to see if it's still preventing the sodium from entering, which would leave them less excitable. This would indicate that the changed Eslicarbazepine-SS-N3 is still an active Na+-blocker.
Bioinformatics